PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperuricemia |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 19 |
| PubMedID- 22095983 | Objective: hyperuricemia is common in patients with metabolic syndrome. |
| PubMedID- 24472219 | The adjusted odds ratio for metabolic syndrome of the hyperuricemia group increased significantly to 1.787 (1.125–2.839) compared with the healthy group. |
| PubMedID- 24527421 | hyperuricemia is associated with metabolic syndrome as well as gout, and the prevalence of hyperuricemia is increasing in korea. |
| PubMedID- 23804456 | High uricemia in humans may protect against oxidative stress, but hyperuricemia also associates with the metabolic syndrome, and urate and uric acid can crystallize to cause gout and renal dysfunctions. |
| PubMedID- 23588856 | hyperuricemia has been attributed to hyperinsulinemia in metabolic syndrome and to decreased uric acid excretion in kidney dysfunction, and is not acknowledged as a main mediator of metabolic syndrome, renal disease, and cardiovascular disorder development. |
| PubMedID- 26141680 | Objectives: to investigate the influence of mets (metabolic syndrome) in combination with hyperuricemia on left ventricular hypertrophy (lvh) in residents in the rural area of northeast china. |
| PubMedID- 22615932 | There is evidence that hyperuricemia is associated with the metabolic syndrome [1], [2] and incident type 2 diabetes [3], [4]. |
| PubMedID- 22712045 | The higher serum uric acid level of hyperuricemia has been associated with metabolic syndrome in studies of health screenees [3,6-9] and in nationwide surveys [10,11]. |
| PubMedID- 20158446 | Background: hyperuricemia is associated with metabolic syndrome and has emerged as a marker for both type 2 diabetes and cardiovascular disease. |
| PubMedID- 21346177 | Most authorities have viewed the presence of hyperuricemia in metabolic syndrome as a secondary response to obesity and hyperinsulinemia and have attributed this to the effects of insulin on proximal tubular urate transport (8), the effect of elevated leptin (9), or altered purine metabolism (10). |
| PubMedID- 22701608 | Additionally, hyperuricemia has been associated with metabolic syndrome and implicated as a risk factor in the etiology of hypertension, atherosclerosis, insulin resistance and diabetes [3], [4]. |
| PubMedID- 26004548 | Conclusions: it can be concluded that hyperuricemia is strongly associated with metabolic syndrome. |
| PubMedID- 26064845 | hyperuricemia has attributed to hyperinsulinemia in metabolic syndrome and decreased excretion of uric acid causing endothelial dysfunction in kidney leads to renal disease and cardiovascular disorders. |
| PubMedID- 21694941 | The close association of hyperuricemia with metabolic syndrome, hypertension and renal insufficiency ensures that nephrologists will see increasing numbers of gout-afflicted patients. |
| PubMedID- 25763281 | Some authors consider hyperuricemia in metabolic syndrome to be the consequence of elevated serum insulin levels, which have been shown to stimulate renal reabsorption of uric acid. |
| PubMedID- 23966810 | We evaluated the combination effect of the alkalizer citrate with the xanthine oxidase inhibitor allopurinol on renal function and uric acid in patients with hyperuricemia associated with obesity and/or metabolic syndrome (mets), who were extracted from among the subjects enrolled in a prospective randomized controlled study aimed at assessing the efficacy of such a combination for improving renal function. |
| PubMedID- 22011411 | hyperuricemia is present in patients with the metabolic syndrome (2) and in subjects with insulin resistance (3). |
| PubMedID- 25356596 | In addition to the morbidity that is attributable to gout, hyperuricemia is also associated with metabolic syndrome, hypertension, and cardiovascular disease. |
| PubMedID- 26425051 | Additionally, hyperuricemia associates directly with hypertension, metabolic syndrome, chronic kidney disease, and peripheral vascular disease (7). |
Page: 1